meddevicedb.com FDA Device Reference

VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST

K083088 Class II Traditional
Decision Date
2009-05-01
Sponsor / Applicant
Nanosphere, Inc.

Technical Specification

510(k) Submission ID K083088
Product Code OCC
Medical Specialty / Panel Microbiology
Regulation Citation 21 CFR 866.3980
Decision Date 2009-05-01
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST received FDA 510(k) clearance under submission number K083088, sponsored by Nanosphere, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2009-05-01.

Classification & Regulation

This clearance is catalogued under FDA product code OCC and 21 CFR 866.3980, within the Microbiology review panel as a Class II device.